Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

DURALITH TAB 300MG DIN 00590665

Status: Cancelled Post Market
Holder: JANSSEN INC
Molecule: LITHIUM CARBONATE

Health Canada record

Active ingredient(s)LITHIUM CARBONATE 300 MG
Dosage formTablet (Extended-Release)
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN05AN01 LITHIUM
Original market date31-Dec-1985
Current status date12-Feb-2010
SourceHealth Canada DPD

Establishment licence of the holder

Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing LITHIUM CARBONATE

DINProductCompanyFormStrengthStatus
02242837APO-LITHIUM CARBONATEAPOTEX INCCapsuleLITHIUM CARBONATE 150 MGMarketed
00461733CARBOLITHBAUSCH HEALTH, CANADA INC.CapsuleLITHIUM CARBONATE 150 MGMarketed
02011239CARBOLITHBAUSCH HEALTH, CANADA INC.CapsuleLITHIUM CARBONATE 600 MGMarketed
00406775LITHANESEARCHLIGHT PHARMA INCCapsuleLITHIUM CARBONATE 300 MGMarketed
02013231LITHANESEARCHLIGHT PHARMA INCCapsuleLITHIUM CARBONATE 150 MGMarketed
02266695LITHMAXAA PHARMA INCTablet (Extended-Release)LITHIUM CARBONATE 300 MGMarketed
02216132PMS-LITHIUM CARBONATE - CAP 150MGPHARMASCIENCE INCCapsuleLITHIUM CARBONATE 150 MGMarketed
02242838APO-LITHIUM CARBONATEAPOTEX INCCapsuleLITHIUM CARBONATE 300 MGDormant
00236683CARBOLITHBAUSCH HEALTH, CANADA INC.CapsuleLITHIUM CARBONATE 300 MGDormant
02231399DOM-LITHIUM CARBONATEDOMINION PHARMACALCapsuleLITHIUM CARBONATE 600 MGCancelled Pre Market
02231397DOM-LITHIUM CARBONATEDOMINION PHARMACALCapsuleLITHIUM CARBONATE 150 MGCancelled Pre Market
02231398DOM-LITHIUM CARBONATEDOMINION PHARMACALCapsuleLITHIUM CARBONATE 300 MGCancelled Pre Market
02304538EURO LITHIUMEURO-PHARM INTERNATIONAL CANADA INCCapsuleLITHIUM CARBONATE 300 MGCancelled Post Market
02304511EURO LITHIUMEURO-PHARM INTERNATIONAL CANADA INCCapsuleLITHIUM CARBONATE 150 MGCancelled Post Market
00328782LITHIZINE CAP 150MGLABS MANEY PAUL LABS, DIVISION OF 471449 (ONT) LTEE/LTD.CapsuleLITHIUM CARBONATE 150 MGCancelled Post Market
00328790LITHIZINE CAP 300MGLABS MANEY PAUL LABS, DIVISION OF 471449 (ONT) LTEE/LTD.CapsuleLITHIUM CARBONATE 300 MGCancelled Post Market
02237443PAL-LITHIUM CARBONATEPALADIN PHARMA INC.CapsuleLITHIUM CARBONATE 600 MGCancelled Post Market
02237441PAL-LITHIUM CARBONATEPALADIN PHARMA INC.CapsuleLITHIUM CARBONATE 150 MGCancelled Post Market
02237442PAL-LITHIUM CARBONATEPALADIN PHARMA INC.CapsuleLITHIUM CARBONATE 300 MGCancelled Post Market
02237008PHL-LITHIUM CARBONATEPHARMEL INCCapsuleLITHIUM CARBONATE 600 MGCancelled Post Market
02237007PHL-LITHIUM CARBONATEPHARMEL INCCapsuleLITHIUM CARBONATE 300 MGCancelled Post Market
02237006PHL-LITHIUM CARBONATEPHARMEL INCCapsuleLITHIUM CARBONATE 150 MGCancelled Post Market
02216140PMS-LITHIUM CARBONATE - CAP 300MGPHARMASCIENCE INCCapsuleLITHIUM CARBONATE 300 MGDormant
02216159PMS-LITHIUM CARBONATE - CAP 600MGPHARMASCIENCE INCCapsuleLITHIUM CARBONATE 600 MGDormant

Notices of Compliance

NOCDateSubmissionReason
18941999-06-07New Drug Submission (NDS)

International API supply for LITHIUM CARBONATE

4 valid EDQM Certificates of Suitability from 4 holders. 16 active FDA Drug Master Files.

Request a quote for DURALITH TAB 300MG

How to read a Canadian DIN record